ArticleViruses2020

An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.

Yuqing Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.